Facebook
Instagram
Linkedin
Youtube
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Search
BioStock
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Home
Tags
STA363
Tag: STA363
Stayble Therapeutics presents phase IIb data within one month
3 November, 2023
Stayble enrols the first patient in herniated disc study
4 September, 2023
Stayble adds disc herniation to the pipeline – study approved
7 March, 2023
NLSDays: Stayble steps up partnering activities
4 October, 2022
Stayble reaches important milestone – completed patient recruitment
5 September, 2022
Stayble sums up and looks ahead
24 August, 2022
Stayble’s pathway to phase III and market
18 July, 2022
10 advantages of Stayble’s treatment
29 June, 2022
KOL sees benefits with Stayble Therapeutics’ treatment
24 May, 2022
Stayble Therapeutics reaches patient recruitment milestone
3 May, 2022
1
2
Page 1 of 2